Patents by Inventor Ben Z. Stanger

Ben Z. Stanger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USING A MULTI-ANALYTE APPROACH FOR DIAGNOSIS AND STAGING A DISEASE
    Publication number: 20230142955
    Abstract: Disclosed herein are methods for evaluating a disease or a condition in a subject. More particularly, disclosed herein are methods for determining or diagnosing a disease, methods for classifying a stage of a disease, methods for treating a disease or methods for assessing the efficacy of a therapy for treating a disease based on the measurement and the computational analysis of various disease-specific biomarkers.
    Type: Application
    Filed: February 26, 2021
    Publication date: May 11, 2023
    Inventors: David Aaron ISSADORE, Zijian YANG, Erica L. CARPENTER, Ben Z. STANGER
  • METHODS FOR ASSESSING RISK FOR CANCER USING BIOMARKERS
    Publication number: 20150017638
    Abstract: The present disclosure is directed to methods and kits for detecting, characterizing, preventing, and treating cancer, e.g., pancreatic cancer, or inflammation, by determining the presence of circulating epithelial in a biological sample and further identifying the tissue of origin using a tissue-specific biomarker, e.g., Pdx-1.
    Type: Application
    Filed: July 18, 2014
    Publication date: January 15, 2015
    Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: ANDREW D. RHIM, Ben Z. Stanger
  • Cell death protein
    Patent number: 5674734
    Abstract: Disclosed is a protein, designated RIP, which contains a death domain at its carboxy terminus and a kinase domain at its amino terminus. RIP interacts with the Fas/APO-1 intracellular domain and the TNFR1 intracellular domain. When expressed in transformed host cells, recombinant RIP promotes apoptosis. Also disclosed are DNA molecules encoding RIP, anti-RIP antibodies, and screening methods for discovering inhibitors of RIP-dependent apoptosis.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: October 7, 1997
    Assignees: President and Fellows of Harvard College, The General Hospital Corporation
    Inventors: Philip Leder, Brian Seed, Ben Z. Stanger, Tae-Ho Lee, Emily Kim